Figure 3. Pooled effect of treatment with VEGFi on clinical outcomes.

*For all-cause mortality, the value presented is number needed to treat (NNT); however for all other outcomes number needed to harm (NNH) is presented. # 8 trials presented either only any thrombotic events or specified arterial and/or venous thromosis and/or pulmonary embolism in addition to any thrombotic events; therefore the included trials (in figure 4) and number of participants for any thrombotic events differed from the arterial, venous thrombosis or pulmonary embolism events.